Fas/FasL system, IL-1β expression and apoptosis in chronic HBV and HCV liver disease

Journal of Viral Hepatitis

Volumn 15, Issue 7, 2008, Pages 515-522

  Bortolami, M ^a   Kotsafti, A ^a   Cardin, R ^a   Farinati, F ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Apoptosis; Fas FasL; HBV; HCV; IL 1

Indexed keywords

FAS LIGAND; INTERLEUKIN 1BETA;

ADULT; AGED; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NICK END LABELING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; FAS LIGAND PROTEIN; FEMALE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LIVER DISEASES; LIVER NEOPLASMS; MALE; MIDDLE AGED;

EID: 44849094280     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2008.00974.x     Document Type: Article

References (39)

1. Koziel MJ. Cellular immune responses against hepatitis C virus. Clin Infect Dis 2005 41 (11 S25 S31.
2. Bertoletti A, Ferrari C. Kinetics of the immune response during HBV and HCV infection. Hepatology 2003 38 (1 4 13.
3. Suda T, Nagata S. Purification and characterization of the Fas-Ligand that induces apoptosis. J Exp Med 1994 179 (3 873 879.
4. Takahashi T, Tanaka M, Inazawa J, Abe T, Suda T, Nagata S. Human Fas ligand: gene structure, chromosomal location and species specificity. Int Immunol 1994 6 : 1567.
5. Shresta S, Pham CT, Thomas DA, Graubert TA, Ley TJ. How do cytotoxic lymphocytes kill their targets? Curr Opin Immunol 1998 10 (5 581 587.
6. Kagi D, Vignaux F, Ledermann B et al. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 1994 265 : 528 530.
7. Pham B, Martinot-Peignoux M, Valla D, Dobois S, Degott C, Mosnier JF. Differential expression of perforin and granzyme B in the liver of patients with chronic hepatitis C. Hum Pathol 2003 34 (8 770 777.
8. Schuchmann M, Galle PR. Apoptosis in liver disease. Eur J Gastroenterol Hepatol 2001 13 (7 785 790.
9. Nagata S, Golstein P. The Fas death factor. Science 1995 267 : 1449 1456.
10. Mochizuki K, Hayashi N, Hiramatsu N et al. Fas antigen expression in liver tissues of patients with chronic hepatitis B. J Hepatology 1996 24 : 1 7.
11. Hiramatsu N, Hayashi N, Katayama K et al. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology 1994 19 (6 1354 1359.
12. Luo KX, Zhu YF, Zhang LX, He HT, Wang XS, Zhang L. In situ investigation of Fas/FasL expression in chronic hepatitis B infection and related liver diseases. J Viral Hepat 1997 4 (5 303 307.
13. Fukuzawa Y, Takahashi K, Furuta K et al. Expression of Fas/FasL (FasL) and its involvement in infiltrating lymphocytes in hepatocellular carcinoma (HCC). J Gastroenterol 2001 36 : 681 688.
14. Gremion C, Grabscheid B, Wolk B et al. Cytotoxic T lymphocytes derived from patients with chronic hepatitis C virus infection kill bystander cells via Fas-FasL interaction. J Virol 2004 78 : 2152 2157.
15. Chen NL, Bai L, Li L et al. Apoptosis pathways of liver cells in chronic hepatitis. WJG 2004 10 (21 3201 3204.
16. Suda T, Okazaki T, Naito Y et al. Expression of the Fas ligand in cells of T cell lineage. J Immunol 1995 154 (8 3806 3813.
17. Roskams T, Libbrecht L, Van Damme B, Desmet V. Fas and Fas ligand: strong co-expression in human hepatocytes surrounding hepatocellular carcinoma; can cancer induce suicide in peritumoral cells? J Pathol 2000 191 : 150 153.
18. Nagao M, Nakajima Y, Hisunaga M et al. The alteration of Fas receptor and ligand system in hepatocellular carcinomas: how do hepatoma cells escape from the host immune surveillance in vivo? Hepatology 1999 30 (2 413 4521.
19. Zhang T, Guo CJ, Li Y et al. Interleukin-1 β induces macrophages inflammatory protein-1β expression in human hepatocytes. Cell Immunol 2003 226 : 45 53.
20. Kato A, Gabay C, Okaya T, Lentsch A. Specific role of interleukin-1 in hepatic neutrophil recruitment after ischemia/reperfusion. AJP 2002 161 (5 1797 1803.
21. Bossu P, Del Grosso E, Cesaroni MP et al. Balance between autocrine interleukin-1 beta and caspases defines life versus death of polymorphonuclear cells. Eur Cytokine Netw 2001 12 (1 177 186.
22. Allison J, Georgiou HM, Strasser A, Vaux DL. Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts. Proc Natl Acad Sci USA 1997 94 : 3943 3947.
23. Yang J, Gallagher SF, Haines K et al. Kupffer cell-derived Fas ligand plays a role in liver injury and hepatocyte death. J Gastrointest Surg 2004 8 (2 166 174.
24. Papakyriakou P, Tzardi V, Valatas V et al. Apoptosis and apoptosis related proteins in chronic viral liver disease. Apoptosis 2002 7 : 133 141.
25. Hayashi N, Mita E. Involvement of Fas system-mediated apoptosis in pathogenesis of viral hepatitis. J Viral Hepatitis 1999 6 : 357 365.
26. Lee SH, Shin MS, Lee HS et al. Expression of Fas and Fas related molecules in human heaptocellular carcinoma. Hum Pathol 2001 32 (3 250 256.
27. Nakamura M, Nagano H, Saccon M et al. Role of the Fas/FasL pathway in combination therapy with interferon-a and fluorouracil against hepatocellular carcinoma in vitro. J Hepatol 2007 46 : 77 88.
28. Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48900 necropsies. Cancer 1954 7 : 462 503.
29. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidium thiocyanate-phenol-choloroform extraction. Anal Biochem 1987 162 : 156 159.
30. Yano H, Fukuda K, Karamaki M et al. Expression of Fas and anti-Fas-mediated apoptosis in human heaptocellular carcinoma cell line. J Hepatol 1996 25 : 454 464.
31. Jarnicki AG, Lysaght J, Todryk S, Mills KH. Suppression of antitumor immunity by IL-10 and TGF-beta producing T cells infiltrating the growing tumor: influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells. J Immunol 2006 177 (2 896 904.
32. Iken K, Huang L, Bekele H, Schmidt EV, Koziel MJ. Apoptosis of activated CD4+ and CD8+ T cell is enhanced by co-culture with the hepatocytes expressing hepatitis C virus (HCV) structural proteins through FasL induction. Virology 2006 346 : 363 372.
33. Chang KM, Thimme R, Melpolder JJ. Differential CD4* and CD8+ T cell responsiveness in hepatitic C virus infection. Hepatology 2001 33 : 267 276.
34. Milich D, Liang TJ. Exploring the biological basis of hepatitis B antigen in hepatitis B virus infection. Hepatology 2003 38 (5 1075 1086.
35. Majumder M, Ghoh AK, Steele R et al. Hepatitis C virus NS5A protein impairs TNF-mediated hepatic apoptosis, but not by anti-Fas antibody in transgenic mice. Virology 2002 294 : 94 105.
36. Otsuka M, Kato N, Taniguchi H et al. Hepatitis C virus core protein inhibits apoptosis via enhanced Bcl-Xl expression. Virology 2002 296 (1 84 93.
37. Zhu N, Ware CF, Lai MM. Hepatitis C virus core protein enhances FADD-mediated apoptosis and suppresses TRADD signaling of tumor necrosis factor receptor. Virology 2001 283 : 178 187.
38. Bortolami M, Venturi C, Giacomelli L et al. Cytokine, infiltrating macrophages and T cell-mediated response to development of primary and secondary human liver cancer. Dig Liver Dis 2002 34 : 794 801.
39. Farinati F, Cardin R, Fiorentino M et al. Imbalance between cytoproliferation and apoptosis in hepatitis C virus related chronic liver disease. J Viral Hepat 2001 8 (1 34 40.